America Uses Supercomputers To Create COVID-19 Vaccines

JAKARTA - Various ways have been done around the world to deal with the COVID-19 disease outbreak. One of the efforts is to make a vaccine, to treat patients infected with the corona virus.

In order to quickly finalize the medicinal ingredients for the corona vaccine, the technology giants and scientific institutions of the United States (US) are working together on a major project. They even used 16 units of supercomputer technology to find the right vaccine mixture for COVID-19.

According to an Insidehpc report, the White House invited a number of technology companies to participate in the project, including IBM, Amazon, the NASA Space Agency, Google and Microsoft. Meanwhile, from universities, namely the Massachusetts Institute Technology (MIT) and Rensselaer Polytechnic Institute (RPI).

At least 16 units of the supercomputer are equipped with 775,000 processor cores and 34,000 graphics cards. With this, the device has a computing power of 330,000 teraflops.

The consortium project will be led by IBM, the White House Office of Science and Technology Policy, and the US Department of Energy. According to NASA Administrator Jim Bridenstine, this supercomputer project can be a hope for everyone in the world to quickly find the right cure for the COVID-19 outbreak.

"I am proud that NASA can lend its supercomputing expertise to assist in the global fight against COVID-19. For more than six decades the agency has used its expertise to meet challenges that benefit people around the world in unexpected ways," said Bridenstine in a statement. in twitter.

Later, NASA will use the Earth science division to operate the supercomputer. Researchers will also include satellite data, which is used as an imaging model of Earth's climate during the coronavirus outbreak.

Researchers working on this consortium project are expected to speed up the calculations needed to slow down and produce a vaccine for the COVID-19 pandemic in the US and help globally.

"America is uniting to fight COVID-19, and that means releasing the full capacity of our world-class supercomputers to rapidly advance scientific research for treatments and vaccines," said Chief US Technology Officer Michael Kratsios.